Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Arianna Scoglio"'
Autor:
Barbara Ensoli, Stefania Bellino, Antonella Tripiciano, Olimpia Longo, Vittorio Francavilla, Simone Marcotullio, Aurelio Cafaro, Orietta Picconi, Giovanni Paniccia, Arianna Scoglio, Angela Arancio, Cristina Ariola, Maria J Ruiz Alvarez, Massimo Campagna, Donato Scaramuzzi, Cristina Iori, Roberto Esposito, Cristina Mussini, Florio Ghinelli, Laura Sighinolfi, Guido Palamara, Alessandra Latini, Gioacchino Angarano, Nicoletta Ladisa, Fabrizio Soscia, Vito S Mercurio, Adriano Lazzarin, Giuseppe Tambussi, Raffaele Visintini, Francesco Mazzotta, Massimo Di Pietro, Massimo Galli, Stefano Rusconi, Giampiero Carosi, Carlo Torti, Giovanni Di Perri, Stefano Bonora, Fabrizio Ensoli, Enrico Garaci
Publikováno v:
PLoS ONE, Vol 5, Iss 11, p e13540 (2010)
UnlabelledAlthough HAART suppresses HIV replication, it is often unable to restore immune homeostasis. Consequently, non-AIDS-defining diseases are increasingly seen in treated individuals. This is attributed to persistent virus expression in reservo
Externí odkaz:
https://doaj.org/article/6ed34be1303c4aca8283aa4593dab48a
Autor:
Guido Palamara, Alessandra Latini, Giuseppe Tambussi, Paolo Monini, Adriano Lazzarin, Barbara Ensoli, Gianpiero D'Offizi, Maria Josè Ruiz Alvarez, Enrico Garaci, Barbara Collacchi, Massimo Giuliani, Arianna Scoglio, Aldo Di Carlo, Chiara Tassan Din, Marina Giulianelli, Maria Carta, Andrea Antinori, Pasquale Narciso, Stefania Bellino, Antonella Tripiciano, Olimpia Longo, Mauro Magnani, Fabrizio Ensoli, Valeria Fiorelli, Vittorio Francavilla, Angela Arancio, Giovanni Paniccia, Raffaele Visintini
Publikováno v:
Vaccine. 28:371-378
The native HIV-1 Tat protein was chosen as vaccine candidate for phase I clinical trials based on its role in the natural infection and AIDS pathogenesis, on the association of Tat-specific immune response with the asymptomatic stage as well as on it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2ab576d949def5c4965dadc95265cd0
https://doi.org/10.1016/j.vaccine.2009.10.038
https://doi.org/10.1016/j.vaccine.2009.10.038
Autor:
Vittorio Francavilla, Olimpia Longo, Adriano Lazzarin, A. Di Carlo, Mauro Magnani, Antonella Tripiciano, Guido Palamara, Fabrizio Ensoli, Angela Arancio, Giuseppe Tambussi, Marinella Giulianelli, Gianpiero D’Offizi, Paolo Monini, C. Tassan Din, Arianna Scoglio, Maria Carta, Giovanni Paniccia, Raffaele Visintini, Pasquale Narciso, Maria Elena Laguardia, Massimo Giuliani, Stefania Bellino, Andrea Antinori, Massimo Campagna, Barbara Ensoli, Valeria Fiorelli, Barbara Collacchi
Publikováno v:
ResearcherID
The native HIV-1 Tat protein was chosen as vaccine candidate for phase I clinical trials in both uninfected (ClinicalTrials.gov identifier: NCT00529698) and infected volunteers (ClinicalTrials.gov identifier: NCT00505401). The rationale was based on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a00dc39673b678e7f54c606b3d7c12f
https://doi.org/10.2174/157488709789957529
https://doi.org/10.2174/157488709789957529
Autor:
Sonia Moretti, Pasqualina Leone, Leonardo Sernicola, Arianna Scoglio, Zuleika Michelini, Iole Macchia, Silvia Baroncelli, Stefano Buttò, Aurelio Cafaro, Maria Rosaria Pavone-Cossut, Jonathan L. Heeney, Antonella Tripiciano, Antonella Caputo, Roberta Bona, Fausto Titti, Barbara Ridolfi, Peter ten Haaft, Emanuele Fanales-Belasio, Maria Teresa Maggiorella, Massimo Ciccozzi, Filomena Nappi, Valeria Fiorelli, Donatella R.M. Negri, Alessandra Borsetti, Andrea Cara, Barbara Ensoli
Publikováno v:
Vaccine. 22:3258-3269
Vaccination with a biologically active Tat protein or tat DNA contained infection with the highly pathogenic SHIV89.6P virus, preventing CD4 T-cell decline and disease onset. Here we show that protection was prolonged, since neither CD4 T-cell declin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::baa32e34abf7625e8dac9cad39190b1c
https://doi.org/10.1016/j.vaccine.2004.03.009
https://doi.org/10.1016/j.vaccine.2004.03.009
Autor:
Mauro Magnani, Barbara Ensoli, Sabrina Dominici, Giordano Serafini, Maria Elena Laguardia, Egidio Brocca-Cofano, Valeria Fiorelli, Riccardo Gavioli, Arianna Scoglio, Laura Chiarantini, Cinzia Fortini, Antonella Tripiciano, Antonella Caputo, Aurelio Cafaro
Publikováno v:
Vaccine. 21:2073-2081
The immunotherapeutic potential of biologically active HIV-1 Tat protein coupled to autologous red blood cells (RBCs) was evaluated in a mouse model. HIV-1 Tat expressed in Escherichia coli and purified to homogeneity was found to be active in viral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49ccfeb2e4cee02d75e190366bc77510
https://doi.org/10.1016/s0264-410x(02)00746-6
https://doi.org/10.1016/s0264-410x(02)00746-6
Autor:
Giovanni Paniccia, Raffaele Visintini, Olimpia Longo, Barbara Ensoli, Adriano Lazzarin, Maria Josè Ruiz Alvarez, Arianna Scoglio, Gianpiero D'Offizi, Maria Carta, Barbara Collacchi, Marina Giulianelli, Andrea Antinori, Pasquale Narciso, Vittorio Francavilla, Guido Palamara, Maria Elena Laguardia, Valeria Fiorelli, Chiara Tassan Din, Aldo Di Carlo, Massimo Giuliani, Antonella Tripiciano, Giuseppe Tambussi, Stefania Bellino, Paolo Monini, Angela Arancio, Mauro Magnani, Fabrizio Ensoli
Publikováno v:
Vaccine. 27(25-26)
A randomized, double blind, placebo-controlled phase I vaccine trial based on the native Tat protein was conducted in HIV-infected asymptomatic individuals. The vaccine was administered five times subcute with alum or intradermally without adjuvant a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5c175d015cb17e80c2d6bd4ae547776
https://pubmed.ncbi.nlm.nih.gov/19208456
https://pubmed.ncbi.nlm.nih.gov/19208456
Autor:
Mauro Magnani, Fabrizio Ensoli, Arianna Scoglio, Maria Elena Laguardia, Antonella Tripiciano, Antonella Caputo, Emanuele Fanales-Belasio, Stefania Bellino, Maria Rosaria Pavone Cossut, Filomena Nappi, Valeria Fiorelli, Iole Macchia, Aurelio Cafaro, Sonia Moretti, Barbara Collacchi, Paolo Monini, Fausto Titti, Giovanni Barillari, Vittorio Francavilla, Barbara Ensoli
Tat is an early regulatory protein that plays a major role in human HIV-1 replication and AIDS pathogenesis, and therefore, it represents a key target for the host immune response. In natural infection, however, Abs against Tat are produced only by a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d5fba388d3a19d7437744fcb70c2a28
http://hdl.handle.net/11577/2376908
http://hdl.handle.net/11577/2376908
Autor:
Paola De Cesaris, Francesco Marampon, Bianca M. Zani, Cristina Giacinti, Arianna Scoglio, Annunziata Mauro, Carmela Ciccarelli
Publikováno v:
Molecular Cancer, Vol 4, Iss 1, p 41 (2005)
Molecular Cancer
Molecular Cancer
Backgroundp21WAF1, implicated in the cell cycle control of both normal and malignant cells, can be induced by p53-dependent and independent mechanisms. In some cells, MEKs/ERKs regulate p21WAF1transcriptionally, while in others they also affect the p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c85a6718dd79f7f83cca2ecb2483ffbf
http://www.molecular-cancer.com/content/4/1/41
http://www.molecular-cancer.com/content/4/1/41
Autor:
Massimo Ciccozzi, Stefano Buttò, Maria Dorrucci, Barbara Collacchi, Fabrizio Ensoli, Valeria Fiorelli, Giovanni Rezza, Alessandro Sinicco, Lina Rachele Tomasoni, Concettina Giannetto, Arianna Scoglio, Barbara Ensoli, Francesco Castelli, Mauro Sciandra, Maria Jose Ruiz-Alvarez, Antonella Tripiciano, Antonella Caputo
The human immunodeficiency virus (HIV) type 1 Tat protein plays a key role in the life cycle of the virus and in pathogenesis and is highly conserved among HIV subtypes. On the basis of this and of safety, immunogenicity, and efficacy findings in mon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5b9b425b07f20fe281b283965d8ca2a
http://hdl.handle.net/2318/41552
http://hdl.handle.net/2318/41552
Autor:
Faiza Rharbaoui, Barbara Ensoli, Stefano Buttò, Aurelio Cafaro, Filomena Nappi, Valeria Fiorelli, Carlos A. Guzmán, Michael Morr, Claudia Link, Antonella Tripiciano, Arianna Scoglio, Stefan Borsutzky, Thomas Ebensen, Peter F. Mühlradt
Publikováno v:
European journal of immunology. 33(6)
A major requirement for HIV/AIDS research is the development of a mucosal vaccine that stimulates humoral and cell-mediated immune responses at systemic and mucosal levels, thereby blocking virus replication at the entry port. Thus, a vaccine prototy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4264921d7e17b93eceb4b8c41b1329a0
https://pubmed.ncbi.nlm.nih.gov/12778472
https://pubmed.ncbi.nlm.nih.gov/12778472